Question

A 50-year-old female presents with a breast lump. Core biopsy confirms ER-positive, HER2-negative invasive ductal carcinoma. According to NICE guidelines, which adjuvant therapy is generally recommended for ER-positive disease post-surgery?

Accepted Answer

Tamoxifen or aromatase inhibitor

Answer

Chemotherapy alone

Answer

Trastuzumab

Answer

Radiotherapy alone

Answer

No adjuvant therapy needed

Practice question

A 50-year-old female presents with a breast lump. Core biopsy confirms ER-positive, HER2-negative invasive ductal carcinoma. According to NICE guidelines, which adjuvant therapy is generally recommended for ER-positive disease post-surgery?